{"entity":{"type":"insider","cik":"0001852129","url":"/insider/0001852129","json_url":"/insider/0001852129.json","name":"Callos Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":30,"first":"2025-03-05","last":"2026-07-30","span_basis":"filed_date"},"name_variants":[{"name":"Callos Andrew","source":"filing","n_filings":30,"first_seen":"2025-03-05","last_seen":"2026-07-30"}],"transactions":[{"id":5795539,"accession":"0001061983-26-000086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000086","line_url":"/filing/0001061983-26-000086#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":79.88,"price_display":"79.88","price_state":"stated","total_value":1118320.0,"total_display":"1,118,320.00","total_whole":"1,118,320","shares_owned_after":58555.0,"shares_owned_after_display":"58,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-30","filed_date":"2026-07-30","scope":"insider"},{"id":5915600,"accession":"0001061983-26-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000073","line_url":"/filing/0001061983-26-000073#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":85.8,"price_display":"85.80","price_state":"stated","total_value":1287000.0,"total_display":"1,287,000.00","total_whole":"1,287,000","shares_owned_after":58555.0,"shares_owned_after_display":"58,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider"},{"id":5843505,"accession":"0001061983-26-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000065","line_url":"/filing/0001061983-26-000065#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":74.08,"price_display":"74.08","price_state":"stated","total_value":1111200.0,"total_display":"1,111,200.00","total_whole":"1,111,200","shares_owned_after":58555.0,"shares_owned_after_display":"58,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-01","scope":"insider"},{"id":6125847,"accession":"0001061983-26-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000047","line_url":"/filing/0001061983-26-000047#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11333.0,"shares_display":"11,333","price_per_share":77.25,"price_display":"77.25","price_state":"stated","total_value":875474.25,"total_display":"875,474.25","total_whole":"875,474","shares_owned_after":58555.0,"shares_owned_after_display":"58,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-05","scope":"insider"},{"id":6014058,"accession":"0001061983-26-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000046","line_url":"/filing/0001061983-26-000046#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15857.0,"shares_display":"15,857","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":1030705.0,"total_display":"1,030,705.00","total_whole":"1,030,705","shares_owned_after":58555.0,"shares_owned_after_display":"58,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-04","scope":"insider"},{"id":6147015,"accession":"0001061983-26-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000045","line_url":"/filing/0001061983-26-000045#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":63.26,"price_display":"63.26","price_state":"stated","total_value":948900.0,"total_display":"948,900.00","total_whole":"948,900","shares_owned_after":58555.0,"shares_owned_after_display":"58,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-04-30","scope":"insider"},{"id":5818378,"accession":"0001061983-26-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000036","line_url":"/filing/0001061983-26-000036#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7449.0,"shares_display":"7,449","price_per_share":66.02,"price_display":"66.02","price_state":"stated","total_value":491782.98,"total_display":"491,782.98","total_whole":"491,783","shares_owned_after":58555.0,"shares_owned_after_display":"58,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-15","scope":"insider"},{"id":5805630,"accession":"0001061983-26-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000030","line_url":"/filing/0001061983-26-000030#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3639.0,"shares_display":"3,639","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":236535.0,"total_display":"236,535.00","total_whole":"236,535","shares_owned_after":66004.0,"shares_owned_after_display":"66,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-03-31","scope":"insider"},{"id":5761422,"accession":"0001061983-26-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000025","line_url":"/filing/0001061983-26-000025#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1930.0,"shares_display":"1,930","price_per_share":62.07,"price_display":"62.07","price_state":"stated","total_value":119795.1,"total_display":"119,795.10","total_whole":"119,795","shares_owned_after":78185.0,"shares_owned_after_display":"78,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-18","scope":"insider"},{"id":5739395,"accession":"0001061983-26-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000028","line_url":"/filing/0001061983-26-000028","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8542.0,"shares_display":"8,542","price_per_share":62.15,"price_display":"62.15","price_state":"stated","total_value":530885.3,"total_display":"530,885.30","total_whole":"530,885","shares_owned_after":74489.0,"shares_owned_after_display":"74,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-18","scope":"insider","n_lines":2},{"id":5818376,"accession":"0001061983-26-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000019","line_url":"/filing/0001061983-26-000019#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1709.0,"shares_display":"1,709","price_per_share":61.03,"price_display":"61.03","price_state":"stated","total_value":104300.27,"total_display":"104,300.27","total_whole":"104,300","shares_owned_after":46149.0,"shares_owned_after_display":"46,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-16","scope":"insider"},{"id":5915597,"accession":"0001061983-26-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000018","line_url":"/filing/0001061983-26-000018#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2582.0,"shares_display":"2,582","price_per_share":60.72,"price_display":"60.72","price_state":"stated","total_value":156779.04,"total_display":"156,779.04","total_whole":"156,779","shares_owned_after":47858.0,"shares_owned_after_display":"47,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-10","scope":"insider"},{"id":5795532,"accession":"0001061983-26-000015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-26-000015","line_url":"/filing/0001061983-26-000015","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":61.87423076923077,"price_display":"61.87","price_state":"stated","total_value":1608730.0,"total_display":"1,608,730.00","total_whole":"1,608,730","shares_owned_after":61440.0,"shares_owned_after_display":"61,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-05","scope":"insider","n_lines":2},{"id":6014052,"accession":"0001061983-26-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000013","line_url":"/filing/0001061983-26-000013#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":886.0,"shares_display":"886","price_per_share":61.62,"price_display":"61.62","price_state":"stated","total_value":54595.32,"total_display":"54,595.32","total_whole":"54,595","shares_owned_after":50440.0,"shares_owned_after_display":"50,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-02","scope":"insider"},{"id":6031079,"accession":"0001061983-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000012","line_url":"/filing/0001061983-26-000012#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":61.93,"price_display":"61.93","price_state":"stated","total_value":928950.0,"total_display":"928,950.00","total_whole":"928,950","shares_owned_after":50440.0,"shares_owned_after_display":"50,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-05","filed_date":"2026-02-05","scope":"insider"},{"id":5739392,"accession":"0001061983-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000011","line_url":"/filing/0001061983-26-000011#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":886.0,"shares_display":"886","price_per_share":62.1,"price_display":"62.10","price_state":"stated","total_value":55020.6,"total_display":"55,020.60","total_whole":"55,021","shares_owned_after":50440.0,"shares_owned_after_display":"50,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-02","scope":"insider"},{"id":5937699,"accession":"0001061983-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000002","line_url":"/filing/0001061983-26-000002#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":60.28,"price_display":"60.28","price_state":"stated","total_value":904200.0,"total_display":"904,200.00","total_whole":"904,200","shares_owned_after":50440.0,"shares_owned_after_display":"50,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6218274,"accession":"0001061983-26-000001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001061983-26-000001","line_url":"/filing/0001061983-26-000001","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1798.0,"shares_display":"1,798","price_per_share":62.61666852057842,"price_display":"62.62","price_state":"stated","total_value":112584.77,"total_display":"112,584.77","total_whole":"112,585","shares_owned_after":50440.0,"shares_owned_after_display":"50,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-02","scope":"insider","n_lines":2},{"id":4342491,"accession":"0001061983-25-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-25-000057","line_url":"/filing/0001061983-25-000057#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1809.0,"shares_display":"1,809","price_per_share":62.44,"price_display":"62.44","price_state":"stated","total_value":112953.96,"total_display":"112,953.96","total_whole":"112,954","shares_owned_after":51353.0,"shares_owned_after_display":"51,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-29","filed_date":"2025-12-30","scope":"insider"},{"id":5160364,"accession":"0001061983-25-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000049","line_url":"/filing/0001061983-25-000049#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1042.0,"shares_display":"1,042","price_per_share":65.96,"price_display":"65.96","price_state":"stated","total_value":68730.32,"total_display":"68,730.32","total_whole":"68,730","shares_owned_after":50660.0,"shares_owned_after_display":"50,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-08","scope":"insider"},{"id":4166951,"accession":"0001061983-25-000048","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-25-000048","line_url":"/filing/0001061983-25-000048#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52486.0,"shares_display":"52,486","price_per_share":65.95,"price_display":"65.95","price_state":"stated","total_value":3461451.7,"total_display":"3,461,451.70","total_whole":"3,461,452","shares_owned_after":50660.0,"shares_owned_after_display":"50,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-05","scope":"insider"},{"id":4043844,"accession":"0001127602-25-016865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-016865","line_url":"/filing/0001127602-25-016865#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8659.0,"shares_display":"8,659","price_per_share":32.04,"price_display":"32.04","price_state":"stated","total_value":277434.36,"total_display":"277,434.36","total_whole":"277,434","shares_owned_after":52028.0,"shares_owned_after_display":"52,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-05","scope":"insider"},{"id":4988791,"accession":"0001127602-25-013404","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-013404","line_url":"/filing/0001127602-25-013404#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4002.0,"shares_display":"4,002","price_per_share":36.68,"price_display":"36.68","price_state":"stated","total_value":146793.36,"total_display":"146,793.36","total_whole":"146,793","shares_owned_after":60687.0,"shares_owned_after_display":"60,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-05","filed_date":"2025-05-05","scope":"insider"},{"id":4631840,"accession":"0001127602-25-011767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-011767","line_url":"/filing/0001127602-25-011767#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2886.0,"shares_display":"2,886","price_per_share":35.78,"price_display":"35.78","price_state":"stated","total_value":103261.08,"total_display":"103,261.08","total_whole":"103,261","shares_owned_after":64689.0,"shares_owned_after_display":"64,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-07","filed_date":"2025-04-07","scope":"insider"},{"id":5211015,"accession":"0001127602-25-009691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-009691","line_url":"/filing/0001127602-25-009691#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20900.0,"shares_display":"20,900","price_per_share":45.14,"price_display":"45.14","price_state":"stated","total_value":943426.0,"total_display":"943,426.00","total_whole":"943,426","shares_owned_after":37663.0,"shares_owned_after_display":"37,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-17","scope":"insider"},{"id":5131435,"accession":"0001127602-25-009712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-009712","line_url":"/filing/0001127602-25-009712#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2775.0,"shares_display":"2,775","price_per_share":44.38,"price_display":"44.38","price_state":"stated","total_value":123154.5,"total_display":"123,154.50","total_whole":"123,155","shares_owned_after":34888.0,"shares_owned_after_display":"34,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-17","scope":"insider"},{"id":4595301,"accession":"0001127602-25-009556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-009556","line_url":"/filing/0001127602-25-009556#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":37663.0,"shares_owned_after_display":"37,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-14","scope":"insider"},{"id":5210850,"accession":"0001127602-25-009355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-009355","line_url":"/filing/0001127602-25-009355#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26771.0,"shares_display":"26,771","price_per_share":43.62,"price_display":"43.62","price_state":"stated","total_value":1167751.02,"total_display":"1,167,751.02","total_whole":"1,167,751","shares_owned_after":37663.0,"shares_owned_after_display":"37,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-13","scope":"insider"},{"id":4349577,"accession":"0001127602-25-008792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-008792","line_url":"/filing/0001127602-25-008792#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3341.0,"shares_display":"3,341","price_per_share":43.27,"price_display":"43.27","price_state":"stated","total_value":144565.07,"total_display":"144,565.07","total_whole":"144,565","shares_owned_after":64434.0,"shares_owned_after_display":"64,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-07","scope":"insider"},{"id":4669298,"accession":"0001127602-25-008316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-008316","line_url":"/filing/0001127602-25-008316#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001852129","owner_name":"Callos Andrew","owner_display_name":"Callos Andrew","owner_url":"/insider/0001852129","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1114.0,"shares_display":"1,114","price_per_share":42.88,"price_display":"42.88","price_state":"stated","total_value":47768.32,"total_display":"47,768.32","total_whole":"47,768","shares_owned_after":67775.0,"shares_owned_after_display":"67,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":33,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001061983","name":"CYTOKINETICS INC","url":"/issuer/0001061983","role":"Officer (EVP, Chief Commercial Officer)","n_filings":30,"first_seen":"2025-03-05","last_seen":"2026-07-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001852129","retrieved_at":"2026-08-27T03:05:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}